Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trial

Authors: Holly M Burke, Mario Chen, Mercy Buluzi, Rachael Fuchs, Silver Wevill, Lalitha Venkatasubramanian, Leila Dal Santo, and Bagrey Ngwira

This study looked at the continuation rates of women who self-injected contraceptives (specifically subcutaneous depot medroxyprogesterone acetate) versus women who were injected by a health care provider, which included community health workers. The paper concluded that women who self-injected were more likely to continue and suggested promoting the ability to self-inject.